Iambic Therapeutics (IAM) IPO deck
Iambic Therapeutics is a clinical-stage biotechnology company deploying generative AI models and automated experimentation to discover and develop small molecule cancer therapies.
Iambic Therapeutics is a clinical-stage biotechnology company deploying generative AI models and automated experimentation to discover and develop small molecule cancer therapies.
%20IPO%20deck){kind=link}